The company aims to provide a solution for treating patients remotely, especially in areas where special surgical procedures are not readily available. XCath offers steerable robotic guidewires that ensure sophisticated percutaneous endovascular intervention, enabling clinicians to get minimally invasive devices to treat life-threatening conditions such as cerebral stroke and ischemic cardiac disease.